Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BYLife (Basel, Switzerland)

Integrated Structural, Physicochemical, Pharmacokinetic and Pharmacodynamic Evaluation of Substituted Phenylcarbonyloxypiperazinopropanols as Antimycobacterial Agents

  • Dominika Nádaská1
  • Tomáš Sádecký1
  • Lucia Račková2
  • Martina Hrčka Dubničková3
  • Fils Andriamainty1
  • Petr Mokrý4
  • Simona Gover1
  • Vladimír Garaj1
  • Jozef Csöllei4
  • Ivan Malík1
4 affiliations
  1. 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, P.O.Box 90, SK-820 18 Bratislava, Slovakia; (T.S.); (F.A.); (V.G.)
  2. 2Institute of Chemistry, Slovak Academy of Sciences, Dúbravská Cesta 9, SK-845 38 Bratislava, Slovakia;
  3. 3Department of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, P.O.Box 90, SK-820 18 Bratislava, Slovakia;
  4. 4Department of Chemical Drugs, Faculty of Pharmacy, Masaryk University in Brno, Palackého Třída 1946/1, CZ-612 00 Brno, Czech Republic; (P.M.); (J.C.)
Read full textPDFCite

Related

  1. Microbiota–Gut–Brain Axis Interactions with CNS Drugs: A Critical Mechanistic Review of Biopharmaceutical, Pharmacokinetic, and Pharmacodynamic Evidence
    PharmaceuticsPeer-reviewedCC BYFull textEurope PMC
  2. Preclinical Pharmacokinetic‐Pharmacodynamic Modeling of Antibody Nanoconjugates for Breast Cancer Treatment
    Anne Rodallec, Cristina Vaghi, Joseph Ciccolini +2
    CPT: pharmacometrics & systems pharmacologyPeer-reviewedCC BY-NC-NDFull textEurope PMC
  3. Caenorhabditis elegans as a Model to Dissect Pharmacokinetic and Pharmacodynamic Relationships of Gabapentinoids
    J. Sultana, J. D. Castano, J. R. E. del Castillo +1
    bioRxivPreprintAll rights reservedFull textPharmacology & toxicologybioRxiv
  4. Optimized Flomoxef Dosing Strategy for Extended-Spectrum Beta-Lactamase-Producing Bacteria, Based on Pooled Pharmacokinetic and Pharmacodynamic Analysis
    Tetsushu Onita, Yui Sano, Nami Kuruma +5
    PharmaceuticsPeer-reviewedCC BYFull textEurope PMC
  5. Phytocannabinoid-drug interactions: pharmacokinetic and pharmacodynamic mechanisms, clinical relevance and toxicological considerations
    Diogo Alexandre Gomes, Wellyngton Vieira Eufrázio, Marcella Silva Ribeiro +6
    Frontiers in toxicologyPeer-reviewedCC BYFull textEurope PMC

Cite

BibTeXRIS
BibTeX
@article{nadaska2026integrated,
  title = {{Integrated Structural, Physicochemical, Pharmacokinetic and Pharmacodynamic Evaluation of Substituted Phenylcarbonyloxypiperazinopropanols as Antimycobacterial Agents}},
  author = {Dominika Nádaská and Tomáš Sádecký and Lucia Račková and Martina Hrčka Dubničková and Fils Andriamainty and Petr Mokrý and Simona Gover and Vladimír Garaj and Jozef Csöllei and Ivan Malík},
  journal = {Life (Basel, Switzerland)},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13705932},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Integrated Structural, Physicochemical, Pharmacokinetic and Pharmacodynamic Evaluation of Substituted Phenylcarbonyloxypiperazinopropanols as Antimycobacterial Agents
AU  - Dominika Nádaská
AU  - Tomáš Sádecký
AU  - Lucia Račková
AU  - Martina Hrčka Dubničková
AU  - Fils Andriamainty
AU  - Petr Mokrý
AU  - Simona Gover
AU  - Vladimír Garaj
AU  - Jozef Csöllei
AU  - Ivan Malík
PY  - 2026
DA  - 2026/09/23
JO  - Life (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13705932
SN  - 2075-1729
ER  -